485 related articles for article (PubMed ID: 29233023)
1. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Ravikumar B; Aittokallio T
Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
[TBL] [Abstract][Full Text] [Related]
2. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
3. Computational polypharmacology: a new paradigm for drug discovery.
Chaudhari R; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
[TBL] [Abstract][Full Text] [Related]
4. Challenges with multi-objective QSAR in drug discovery.
Lambrinidis G; Tsantili-Kakoulidou A
Expert Opin Drug Discov; 2018 Sep; 13(9):851-859. PubMed ID: 29996683
[TBL] [Abstract][Full Text] [Related]
5. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
Reyes-Parada M; Iturriaga-Vasquez P
Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
[TBL] [Abstract][Full Text] [Related]
6. An up-to-date overview of computational polypharmacology in modern drug discovery.
Chaudhari R; Fong LW; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2020 Sep; 15(9):1025-1044. PubMed ID: 32452701
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W; Bai Y; Wang Y; Xiao W
Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
[TBL] [Abstract][Full Text] [Related]
8. AI for targeted polypharmacology: The next frontier in drug discovery.
Cichońska A; Ravikumar B; Rahman R
Curr Opin Struct Biol; 2024 Feb; 84():102771. PubMed ID: 38215530
[TBL] [Abstract][Full Text] [Related]
9. Using reverse docking for target identification and its applications for drug discovery.
Lee A; Lee K; Kim D
Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
Dutta D; Das R; Mandal C; Mandal C
J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
[TBL] [Abstract][Full Text] [Related]
11. Web-Based Tools for Polypharmacology Prediction.
Awale M; Reymond JL
Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
[TBL] [Abstract][Full Text] [Related]
12. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacology: challenges and opportunities in drug discovery.
Anighoro A; Bajorath J; Rastelli G
J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
[TBL] [Abstract][Full Text] [Related]
14. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
Ma X; Lv X; Zhang J
Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
[TBL] [Abstract][Full Text] [Related]
15. Dual or multi-targeting inhibitors: The next generation anticancer agents.
Raghavendra NM; Pingili D; Kadasi S; Mettu A; Prasad SVUM
Eur J Med Chem; 2018 Jan; 143():1277-1300. PubMed ID: 29126724
[TBL] [Abstract][Full Text] [Related]
16. Providing data science support for systems pharmacology and its implications to drug discovery.
Hart T; Xie L
Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
[TBL] [Abstract][Full Text] [Related]
17. In silico methods to address polypharmacology: current status, applications and future perspectives.
Lavecchia A; Cerchia C
Drug Discov Today; 2016 Feb; 21(2):288-98. PubMed ID: 26743596
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacology: drug discovery for the future.
Reddy AS; Zhang S
Expert Rev Clin Pharmacol; 2013 Jan; 6(1):41-7. PubMed ID: 23272792
[TBL] [Abstract][Full Text] [Related]
19. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
20. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
